single oral dose of 6 g Chlorella tablets containing 15 mg lutein to healthy volunteers, blood serum lutein concentration increased and reached a maximum of average 850 pmol/mL serum about one and a half-fold from the fasting conditions 12 , and the concentration was maintained over a 3-day period. Chlorella, therefore, appears to be a good dietary source for improving lutein bioavailability.
On the other hand, carotenoids are known to be present in both human plasma and erythrocytes 13 . As a polar carotenoid, lutein is predominant in erythrocyte membranes 14 . Previous animal and human studies suggested that lutein supplementation resulted in improved erythrocyte antioxidant status and decreased oxidative stress, which may contribute to the prevention of life-threatening diseases, especially senile dementia 15 . We previously observed that senile dementia s erythrocytes contain much higher concentration of lipid hydroperoxides than normal subjects 21 . And we observed pure lutein supplementation decreased the erythrocyte hydroperoxides in normal subjects 22 . While the importance of erythrocyte lutein has been suggested, there is little information from human trials regarding food sources that could efficiently supplement lutein to erythrocyte membranes. In this study, we hypothesized that continuous dietary intake of Chlorella might increase the lutein level of human erythrocytes. To evaluate the hypothesis, we performed a 2-month single arm human study with Chlorella
EXPERIMENTAL PROCEDURES

Materials
Lutein, zeaxanthin, b-cryptoxanthin and lycopene were purchased from Extrasynthese Lyon, France . Echinenone, α-carotene, b-carotene, pyrogallol, methanol, ammonium acetate, and methyl tert-butyl ether MTBE were obtained from Wako Osaka, Japan . Chlorella tablets, consisting of Chlorella powder Biorinck ® , were kindly provided by Chlorella Industry Fukuoka, Japan . Each tablet 200 mg contained 0.71 mg lutein, 0.06 mg zeaxanthin, 0.01 mg α-carotene, and 0.03 mg b-carotene for carotenoids, and 0.04 mg α-tocopherol for vitamin E. All other reagents were of analytical grade.
Methods
Supplementation study
The present study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects were approved by the ethics committee of Chlorella Industry C., Ltd. ethics no. PMKK-2011-001 . Exclusion criteria included pregnancy, lactation, and severe medical illness. Twelve healthy subjects aged 29-61 years; six men and six women participated in this study. Written informed consent was obtained from all subjects according to the criterion of the ethics committee.
Subjects took 15 tablets containing 10.67 mg lutein, 0.99 mg zeaxanthin, 0.12 mg α-carotene, 0.51 mg b-carotene and 0.53 mg α-tocopherol 3 times per day at breakfast, lunchtime, and dinner for 2 months. Thus, the daily dose of Chlorella was 9 g/day equivalent to 32 mg lutein/day . At one month and 2 months after the Chlorella supplementation, blood was collected into a tube with ethylenediamine tetraacetic acid as an anticoagulant. One month after completing the ingestion trial one-month observation period , blood was also collected. The blood samples were subjected to centrifugation at 1000 g for 10 min at 4 . After the plasma and buffy coat were removed, erythrocytes were washed 3 times with phosphate buffered saline pH 7.4 to prepare packed cells. The packed cells were immediately subjected to determination of carotenoids. Plasma samples were stored at 80 until analysis.
Extraction of carotenoids from erythrocytes
Two mL of packed cells were diluted with 2 mL of water, and were mixed with 4 mL of 80 mmol/L ethanolic pyrogallol, 0.8 mL of 1.8 mol/L aqueous KOH, and 125 μL of 1 μmol/L ethanolic echinenone an internal standard . After addition of 1 mL of 0.1 mol/L aqueous sodium dodecyl sulfate, the sample was mixed with 12 mL of hexane/dichloromethane 5:1, v/v, containing 2.4 mmol/L butylated hydroxytoluene for extraction of erythrocyte carotenoids. The extract was purified by Sep-Pak silica cartridge Waters, Milford, MA , and then subjected to HPLC coupled with ultraviolet UV detection 14 . These extraction procedures were conducted under subdued yellow light to minimize photo degradation of the carotenoids.
Measurement of carotenoids and blood chemistries
A C30 carotenoid column 4.6 250 mm, 5 μm; YMC, Kyoto, Japan was used, and the column was eluted using a binary gradient consisting of the following HPLC solvents: A, methanol/MTBE/water 83:15:2 v/v/v, containing 3.9 mmol/L ammonium acetate , and B, methanol/MTBE/ water 8:90:2 v/v/v, containing 2.6 mmol/L ammonium acetate . The gradient profile was as follows: 0-12 min, 10-55 B linear; 12-20 min, 55-100 B linear; 20-25 min, 100 B linear; and 25-27 min, 100-10 . The flow rate was adjusted to 1 mL/min, and the column temperature was maintained at 30 . The column eluent was sent to a UV detector UV-2075 PLUS, JASCO, Tokyo, Japan for monitoring lutein and other carotenoids at 463 nm. Concentrations of erythrocyte carotenoids were calculated using an equation corresponding to the standard curve of each carotenoid and were adjusted by the percentage recovery of the added echinenone the internal standard .
Plasma lutein and other carotenoids were determined by HPLC-UV 14 . Plasma α-tocopherol was measured by HPLC with fluorescence detection 16 . Blood characteristics were analyzed using standardized methods.
Statistical analyses
Data were expressed as mean values and standard deviations. All data were analyzed by a normality test and a Friedman test followed by Scheffe s method with non-normally distributed data. Meanwhile, comparisons of data collected before and after supplementation were analyzed by paired t-tests with normally distributed data, and Wilcoxon signed-rank test for non-normally distributed data. Correlative relationships were assessed with Spearman s rank correlation coefficient with abnormally distributed data. These statistical analyses were conducted using Excel Toukei 2010 Social Survey Research Information, Tokyo, Japan .
RESULTS
Blood biochemical measurements before and after the 2-month Chlorella ingestion trial are shown in Table 1 . Among these parameters, plasma α-tocopherol was significantly increased by Chlorella ingestion, not surprising given the substantial amount of α-tocopherol present in Chlorella. Significant differences were observed in albumin, alkaline phosphatase ALP , HDL cholesterol, platelets, leucocytes, erythrocytes, mean corpuscular volume MCV , mean corpuscular hemoglobin concentration MCHC , and hematocrit after Chlorella ingestion. However, these changes were small and were found to be within normal ranges.
Before Chlorella supplementation, six carotenoids lutein, zeaxanthin, b-cryptoxanthin, α-carotene, b-carotene, and lycopene were detected in erythrocytes and plasma Fig. 1 . Among these carotenoids, lutein was predominant in erythrocytes, and showed a 4-fold increase from 14 to 54 pmol/mL packed cells after 1 month of Chlorella ingestion Table 2 . The concentration was then maintained during the supplementation period. Erythrocyte lutein decreased to a basal level 17 pmol/mL packed cells 1 month after cessation of Chlorella ingestion onemonth observation period . These results indicate that daily Chlorella intake would be effective for improving and maintaining erythrocyte lutein concentrations in humans. Table 1 Physical and haematological parameters before and after the administration of Chlorella tablets (9 g/day/subject, 32 mg lutein/day/subject) (Mean values and standard deviations).
Like lutein, zeaxanthin increased in erythrocytes Table  2 , likely due to the presence of zeaxanthin in the Chlorella tablets. Although not significant, erythrocyte α-carotene and b-carotene showed increases. The carotenoid lutein, zeaxanthin, α-carotene, and b-carotene levels were proportional between erythrocytes and plasma Table 3 and Fig. 2 . It is therefore likely that ingested carotenoids were absorbed from the intestine and incorporated into blood plasma and erythrocytes. Polar carotenoids such as lutein and zeaxanthin would likely be transferred from plasma lipoprotein particles to erythrocyte lipid membranes.
DISCUSSION
Lutein, a polar carotenoid, has received attention as a potential nutraceutical agent 17 . Chlorella algae contains high amounts of lutein 11 , and a previous study suggested that Chlorella intake influences serum lutein levels 12 . With a single oral dose of Chlorella a 6 g Chlorella tablet, containing 15 mg lutein , serum lutein concentration reportedly increased about one and a half-fold, but erythrocyte lutein concentrations were not investigated. On the other hand, daily intake of mixed frozen spinach and corn containing a total of 11 mg lutein for 2 months increased serum lutein levels by 2-fold 18 , but characterization of erythrocytes was not conducted. Supplementation of 1 egg yolk containing 0.14 mg lutein for 1 month was also effective at increasing serum lutein concentrations by 1.25-fold 19 . Thus, it is likely that lutein-rich food e.g., Chlorella, spinach, and corn would be useful for improving lutein bioavailability. However, the effect of long-term intake of Chlorella on serum and erythrocyte lutein has not been thoroughly investigated. Thus, it has not been determined whether Chlorella can efficiently supply lutein to human erythrocytes. In this study, we conducted a 2-month single arm human study, and examined the efficacy of 1 or 2 months of Chlorella ingestion on erythrocyte and plasma lutein levels. The subjects received a rather high dose of Chlorella lutein 32 mg/day because we felt it would facili- Fig. 1 UV-HPLC chromatograms of erythrocyte (a) and plasma carotenoids (b) taken before (dotted line) and after 2-month supplementation (solid line) of Chlorella tablets (9 g Chlorella/day; equivalent to 32 mg lutein/day). Peaks are identified as follows: 1, lutein; 2, zeaxanthin; 3, b-cryptoxanthin; 4, echinenone (internal standard); 5, α-carotene; 6, b-carotene; 7, lycopene.
Table 2
Changes in carotenoids contents in erythrocytes and plasma taken before and after administration of Chlorella (32 mg lutein/day/subject) (Mean values and standard deviations).
tate our analysis of the transport of lutein from plasma lipoprotein to erythrocyte lipid membranes. Chlorella intake resulted in an increase of plasma α-tocopherol concentration. No meaningful changes were observed in other parameters of blood biochemistry Table  1 . These results may suggest the safety of Chlorella supplementation. After Chlorella ingestion, plasma lutein concentration increased and reached a maximum of 1260 pmol/mL plasma about 3-fold above basal levels Fig. 1 and Table 2 . Considering the results of previous studies 12, 18, 19 and our findings Fig. 1 and Table 2 , daily intake of Chlorella leads to increased plasma lutein in normal subjects. These results confirm that Chlorella is a good dietary source for improving lutein levels in blood. Interestingly, compared to plasma lutein concentrations, there was a greater increase in erythrocyte lutein. Erythrocyte lutein showed an increase of 4-fold after the Chlorella ingestion Table 2 . However, we found that erythrocyte lutein returned to basal levels after 1 month without consuming Chlorella. Similar changes were observed in plasma lutein. Therefore, continuous Chlorella intake would be important for maintaining erythrocyte lutein at significant levels.
In addition to lutein, we assessed other carotenoids in erythrocytes and plasma. The relative amounts of the carotenoids were in the following order: lutein, b-cryptoxanthin, zeaxanthin, b-carotene, lycopene and α-carotene Table 2 . These data support our previous finding that polar carotenoids are the most prevalent carotenoids in human erythrocytes 14 . Chlorella tablets contained lutein, zeaxanthin, α-carotene, and b-carotene, and these carotenoids were distributed between plasma and erythrocytes in fairly predictable ratios Table 3 and Fig. 2 . It is plausible that polar and nonpolar carotenoids are located in the outer and inner regions of plasma lipoproteins, respectively, facilitating the transfer of outer lutein from lipoprotein to erythrocyte outer lipid bilayers 20 .
CONCLUSIONS
In conclusion, we performed a 2-month single arm human study and provided evidence that Chlorella is an effective dietary source of carotenoids. In particular, it elevated lutein levels in plasma and erythrocytes. We previously found that there was a higher accumulation of phospholipid hydroperoxide, an oxidative stress marker, in erythrocytes of dementia patients 15, 21 . Erythrocytes high in lipid hydroperoxides have been suggested to have a decreased ability to transport oxygen to the brain and may impair blood rheology, thus facilitating dementia. In the present study, orally administered Chlorella lutein was incorporated into erythrocytes at high concentrations. Such lutein may have the potential to act as an important antioxidant for erythrocytes, and it might contribute to the prevention of dementia. This possibility warrants the testing of Chlorella in in vivo dementia models with an eventual goal of use in human therapy.
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